AI assistant
GENTEX CORP — Director's Dealing 2024
Feb 21, 2024
30893_dirs_2024-02-21_69aaa5c4-73cc-4ada-9513-9f30da6ce1ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2024-02-20
Reporting Person: Ryan Scott P (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-20 | Common Stock | A | 7636.00 | $0.00 | Acquired | 35233.00 | Direct |
| 2024-02-20 | Common Stock | F | 3708.00 | $35.0111 | Disposed | 31525.00 | Direct |
| 2024-02-20 | Common Stock | F | 2576.00 | $35.0111 | Disposed | 28949.00 | Direct |
| 2024-02-20 | Common Stock | M | 12500.00 | $22.94 | Acquired | 41449.00 | Direct |
| 2024-02-20 | Common Stock | S | 12500.00 | $34.996 | Disposed | 28949.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | Employee Stock Option (Right to buy) | $22.94 | M | 12500.00 | Disposed | 2028-02-15 | Common Stock (12500.00) | Direct |
Footnotes
F1: 7,636 shares are performance based shares where the total number of shares granted were based on long term performance incentives.
F2: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price.
F3: This transaction was executed in multiple trades at prices ranging from $34.96 to $35.05. The price reported above reflects the weighted average price.
F4: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.